Exelixis (EXEL) FCF Margin Growth (1y) (2011 - 2026)
Exelixis (EXEL) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Exelixis |
13.72 Bn |
12.95 Bn |
590.86 Mn |
345.00 |
| Date | Value |
|---|
| Apr 3, 2026 |
345.00 |
| Jan 2, 2026 |
1,383.00 |
| Oct 3, 2025 |
-45.00 |
| Jul 4, 2025 |
-961.00 |
| Apr 4, 2025 |
2,363.00 |
| Jan 3, 2025 |
4,223.00 |
| Sep 27, 2024 |
2,589.00 |
| Jun 28, 2024 |
-675.00 |
| Mar 29, 2024 |
-380.00 |
| Dec 29, 2023 |
-1,563.00 |
| Sep 29, 2023 |
-262.00 |
| Jun 30, 2023 |
1,881.00 |
| Mar 31, 2023 |
-2,221.00 |
| Sep 30, 2022 |
1,328.00 |
| Jul 1, 2022 |
-4,364.00 |
| Apr 1, 2022 |
3,030.00 |
| Apr 2, 2021 |
-1,379.00 |
| Apr 3, 2020 |
-5,152.00 |
| Sep 27, 2019 |
-3,812.00 |
| Jun 28, 2019 |
61,916.00 |
